University of California San Francisco
Give to UCSFA new digital headset designed to measure alterations in brain function could change decisions about how quickly an athlete is ready to return to play after a concussion.
Long COVID symptoms can persist for a year after initial infection, or re-emerge months later after disappearing.
UCSF Benioff Children’s Hospital Oakland’s craniofacial clinic treats more than 400 children each year for head shape conditions with helmet therapy.
An experimental blood test that reflects injury to nerve cells from multiple sclerosis (MS) was found to work for children with MS and other neurological conditions, even when they are symptom-free.
Taking daily medication can be a challenge for many, leading to increased viral load over time. Injectable therapies remove that challenge.
A common mutation can help people infected with the COVID-19 virus avoid developing any symptoms.
Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, but remained high for those living at home.
A new study shows that newborn screening for SCID is the only factor that actually boosts survival rates.
As part of its miniseries on Black excellence in STEM, Carry the One Radio interviewed UCSF’s Akinyemi Oni-Orisan, PharmD, PhD. The assistant professor of clinical pharmacy shares how he’s improving cardiovascular care for everyone and how he inspires confidence in himself and his students. Find it on your favorite podcast forum.
UCSF infectious disease specialist Michael Peluso, MD, who co-leads one of the world’s oldest studies of long COVID, discusses the condition’s mysteries.
In a breakthrough, “HT” became the first person in the world to receive gene-corrected stem cells for Artemis-SCID.
Quantitative Biosciences Institute’s Nevan Krogan reflects back on the COVID-19 pandemic and how internal and external communications, funding and international partnerships all contributed to a speedy COVID-19 response.
Two UCSF scientists – James Gardner, MD, PhD, and Rebeca de Pavia Fróes Rocha, PhD – have received Pew awards for their work in immunology as part of a program that supports promising early-career investigators.
Two new oral polio vaccines will help limit the amount of new polio strains and outbreaks by genetically engineering weakened polio virus in the oral vaccine to reduce reversion to dangerous forms.
Julia Adler-Milstein, PhD, has been appointed chief of the newly created Division of Clinical Informatics and Digital Transformation (DoC-IT) at UCSF. The new division will promote the integration and application of information technology to improve patient care.
As mental health needs rise in California, the UCSF Child & Adolescent Psychiatry Portal (CAPP) helps educate and train primary care physicians and pediatrics to provide support to patients with psychiatric needs.
Oncology specialists from around the globe will gather for the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest cancer therapies, technologies, research and education.
Taking into account genetic factors that can change PSA levels not associated with cancer, the screening accuracy can be improved.
Face masks remain crucial in preventing the spread of COVID-19, even with vaccine availability. The decision to wear masks depends on vaccination status, risk factors, and local hospitalizations. Medical N95, KN95, or KF94 masks offer the best protection.